4//SEC Filing
Benson Buzz 4
Accession 0001209191-13-005163
CIK 0001168197other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:13 PM ET
Size
19.1 KB
Accession
0001209191-13-005163
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
Benson Buzz
Director
Transactions
- Conversion
Common Stock
2013-01-30+788,834→ 804,210 total(indirect: By funds) - Purchase
Common Stock
2013-01-30$9.00/sh+50,000$450,000→ 854,210 total(indirect: By funds) - Conversion
Series B Convertible Preferred Stock
2013-01-30−8,334→ 0 total(indirect: By funds)→ Common Stock (9,700 underlying) - Conversion
Series E Convertible Preferred Stock
2013-01-30−388,074→ 0 total(indirect: By funds)→ Common Stock (188,215 underlying) - Conversion
Series D-1 Convertible Preferred Stock
2013-01-30−766,284→ 0 total(indirect: By funds)→ Common Stock (445,977 underlying) - Conversion
Series F Convertible Preferred Stock
2013-01-30−298,851→ 0 total(indirect: By funds)→ Common Stock (144,942 underlying)
Footnotes (13)
- [F1]The total represents shares received upon conversion of shares of Series B, Series D-1, Series E and Series F convertible preferred stock.
- [F10]SHF III owned these shares of Series D-1 Convertible Preferred Stock.
- [F11]The Series E and Series F Convertible Preferred Stock converted into common stock on a 0.485-for-1 basis and had no expiration date.
- [F12]SHF III owned 201,772 shares of Series E Convertible Preferred Stock and SHOF owned 186,302 shares of Series E Convertible Preferred Stock.
- [F13]SHF III owned 68,966 shares of Series F Convertible Preferred Stock and SHVF owned 229,885 shares of Series F Convertible Preferred Stock.
- [F2]Effective immediately prior to the closing of the issuer's initial public offering of its common stock, each share of Series B convertible preferred stock automatically converted into 1.164 shares of common stock, each share of Series D-1 convertible preferred stock automatically converted into 0.582 shares of common stock and each share of Series E and Series F convertible preferred stock automatically converted into 0.485 shares of common stock. The convertible preferred stock had no expiration date.
- [F3]The total includes 592,660 shares held by SightLine Healthcare Fund III, L.P. ("SHF III"), 100,056 shares held by SightLine Healthcare Opportunity Fund, LLC ("SHOF") and 111,494 shares held by SightLine Healthcare Vintage Fund, L.P. ("SHVF").
- [F4]The reporting person is a Managing Director of each of (a) SightLine Healthcare Management III, L.P., the general partner of SHF III, (b) SightLine Opportunity Management, LLC, the managing member of SHOF and (c) SightLine Vintage Management, LLC, the general partner of SHVF. The reporting person may be deemed to beneficially own the reported securities but disclaims beneficial ownership of such reported securities except to the extent of his pecuniary interest therein. The filing of this statement shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of the equity securities covered by this statement.
- [F5]These shares were purchased by SHVF in issuer's initial public offering.
- [F6]The total includes 592,660 shares held by SHF III, 100,056 shares held by SHOF and 161,494 shares held by SHVF.
- [F7]The Series B Convertible Preferred Stock converted into common stock on a 1.164-for-1 basis and had no expiration date.
- [F8]SHOF owned these shares of Series B Convertible Preferred Stock.
- [F9]The Series D-1 Convertible Preferred Stock converted into common stock on a 0.582-for-1 basis and had no expiration date.
Documents
Issuer
LIPOSCIENCE INC
CIK 0001168197
Entity typeother
Related Parties
1- filerCIK 0001567218
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:13 PM ET
- Size
- 19.1 KB